1. 2824 Efficacy of B-raf and MEK inhibitor on human anaplastic thyroid cancer cell lines. (September 2015) Authors: Kurata, K.; Onoda, N.; Noda, S.; Kashiwagi, S.; Asano, Y.; Takashima, T.; Hirakawa, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3‐D Intrinsic and Scattering Seismic Attenuation Structures Beneath Kyushu, Japan. Issue 8 (28th July 2020) Authors: Shito, A.; Matsumoto, S.; Ohkura, T.; Shimizu, H.; Sakai, S.; Iio, Y.; Takahashi, H.; Yakiwara, H.; Watanabe, T.; Kosuga, M.; Okada, T.; Yoshimi, M.; Asano, Y. Journal: Journal of geophysical research Issue: Volume 125:Issue 8(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A possible contribution of lipocalin‐2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis. (11th June 2015) Authors: Takahashi, T.; Asano, Y.; Noda, S.; Aozasa, N.; Akamata, K.; Taniguchi, T.; Ichimura, Y.; Toyama, T.; Sumida, H.; Kuwano, Y.; Tada, Y.; Sugaya, M.; Kadono, T.; Sato, S. Journal: British journal of dermatology Issue: Volume 173:Number 3(2015:Sep.) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A possible contribution of lipocalin‐2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis. (11th June 2015) Authors: Takahashi, T.; Asano, Y.; Noda, S.; Aozasa, N.; Akamata, K.; Taniguchi, T.; Ichimura, Y.; Toyama, T.; Sumida, H.; Kuwano, Y.; Tada, Y.; Sugaya, M.; Kadono, T.; Sato, S. Journal: British journal of dermatology Issue: Volume 173:Number 3(2015:Sep.) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A possible contribution of lipocalin‐2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis. (1st September 2015) Authors: Takahashi, T.; Asano, Y.; Noda, S.; Aozasa, N.; Akamata, K.; Taniguchi, T.; Ichimura, Y.; Toyama, T.; Sumida, H.; Kuwano, Y.; Tada, Y.; Sugaya, M.; Kadono, T.; Sato, S. Journal: British journal of dermatology Issue: Volume 173:Number 3(2015:Sep.) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A potential contribution of antimicrobial peptide LL‐37 to tissue fibrosis and vasculopathy in systemic sclerosis. (1st December 2016) Authors: Takahashi, T.; Asano, Y.; Nakamura, K.; Yamashita, T.; Saigusa, R.; Ichimura, Y.; Toyama, T.; Taniguchi, T.; Yoshizaki, A.; Tamaki, Z.; Tada, Y.; Sugaya, M.; Kadono, T.; Sato, S. Journal: British journal of dermatology Issue: Volume 175:Number 6(2016) Page Start: 1195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A potential contribution of antimicrobial peptide LL‐37 to tissue fibrosis and vasculopathy in systemic sclerosis. (30th August 2016) Authors: Takahashi, T.; Asano, Y.; Nakamura, K.; Yamashita, T.; Saigusa, R.; Ichimura, Y.; Toyama, T.; Taniguchi, T.; Yoshizaki, A.; Tamaki, Z.; Tada, Y.; Sugaya, M.; Kadono, T.; Sato, S. Journal: British journal of dermatology Issue: Volume 175:Number 6(2016) Page Start: 1195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A potential contribution of psoriasin to vascular and epithelial abnormalities and inflammation in systemic sclerosis. (3rd August 2017) Authors: Takahashi, T.; Asano, Y.; Yamashita, T.; Nakamura, K.; Saigusa, R.; Miura, S.; Ichimura, Y.; Toyama, T.; Hirabayashi, M.; Taniguchi, T.; Yoshizaki, A.; Sato, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 2(2018) Page Start: 291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A potential contribution of trappin‐2 to the development of vasculopathy in systemic sclerosis. (1st January 2019) Authors: Miyagawa, T.; Asano, Y.; Saigusa, R.; Hirabayashi, M.; Yamashita, T.; Taniguchi, T.; Takahashi, T.; Nakamura, K.; Miura, S.; Yoshizaki, A.; Miyagaki, T.; Sato, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 4(2019) Page Start: 753 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AB0387 TREATMENT STATUS FOR OSTEOPOROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: CROSS-SECTIONAL ANALYSIS FROM A LUPUS REGISTRY OF NATIONWIDE INSTITUTIONS (LUNA). (2nd June 2020) Authors: Sada, K. E.; Hayashi, K.; Asano, Y.; Katayama, Y.; Hiramatsu Asano, S.; Ohashi, K.; Morishita, M.; Watanabe, H.; Narazaki, M.; Matsumoto, Y.; Yajima, N.; Yoshimi, R.; Shimojima, Y.; Ono, S.; Kajiyama, H.; Ichinose, K.; Sato, S.; Fujiwara, M.; Wada, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗